MERIT CRO
Yijun Huang is the CEO and President, CTO, and Managing Partner at MERIT CRO. In addition, currently serving as Venture Partner at Mianus Capital. Previously, worked as a Senior Scientist at the Dept. of Ophthalmology at the University of Wisconsin - Madison and as VP, Engineering at Topcon Medical Systems, Inc. Holds a Ph.D. in Bioengineering from the University of Pennsylvania and completed Executive Education in Leading Product Development at Harvard Business School.
MERIT CRO
MERIT is an innovative clinical trial endpoint services expert providing reliable and attentive expertise in our therapeutic areas. You can feel confident in our proven track record; we have supported 12 of the top 20 global pharmaceutical companies. Our clients rely on us as a trusted R&D partner. We prioritize a collaborative, partnership-driven approach for all projects with scalable solutions and personalized attention. If you’re looking for a partner that will bring dedication and expertise to your clinical trial, consider MERIT.